4DMedical Ltd (AU:4DX) has released an update.
4DMedical Ltd, a pioneer in respiratory imaging technology, reported a significant revenue increase of 422% to $3.8m for FY2024, highlighting a robust cash position of $30.6 million. Key strategic moves included a billing agreement for Medicare beneficiaries, a partnership with West Los Angeles VA using XV Technology®, and the successful commercial integration of Imbio’s portfolio of lung analysis tools. The company is also advancing towards a reseller agreement with Philips, which is set to bolster their commercial opportunities in the U.S. market.
For further insights into AU:4DX stock, check out TipRanks’ Stock Analysis page.
